Loading...

Intellectia LogoIntellectia
AI Trading Bot
Features
Markets
News
Resources
Pricing
Get Started
  1. Home
  2. Stock
  3. INMD
INMD logo

INMD Should I Buy

-
$
0.000
0.000(0.000%)
At close
0.000(0.000%)Aft-market
ET
$
0.000
0.000(0.000%)
At close
0.000(0.000%)Aft-market
ET
OverviewStock Price PredictionTechnicalValuationFinancialsEarningsShould I BuyNews & Events
an image of Intellectia Logoan image of Intellectia

Most Trusted AI Platform for Winning Trades

TwitterYoutubeQuoraDiscordLinkedinTelegram

Copyright © 2026 Intellectia.AI. All Rights Reserved.

Company

  • Home
  • Contact
  • About Us
  • Press
  • Privacy
  • Terms of Service
  • Service Terms of Use

Resources

  • Blog
  • Tutorial
  • Help Center
  • Affiliate Program

Markets

  • Market Analysis
  • Crypto
  • Featured Screeners
  • AI Earnings Calendar
  • Market Movers
  • Stock Monitor
  • Economic Calendar
  • All US Stocks
  • All Cryptos

Tools

  • Dividend Calculator
  • Dividend Yield Calculator
  • Options Profit Calculator

Features

  • QuantAI Alpha Pick
  • SwingMax Portfolio
  • Swing Trading
  • AI Stock Picker
  • Whales Auto Tracker
  • Daytrading Center
  • Patterns Detection
  • AI Screener
  • Financial AI Agent
  • Backtesting Playground
  • AI Earnings Prediction
  • Stock Monitor
  • Technical Analysis

News

  • Overview
  • Top News
  • Daily Market Brief
  • Earnings Analysis
  • Newswire
  • Stock News
  • Crypto News
  • Institution News
  • Congress News
  • Monitor News

Compare

  • TradingView
  • SeekingAlpha
Intellectia

Should You Buy Inmode Ltd (INMD) Today? Analysis, Price Targets, and 2026 Outlook.

Conclusion
Hold
Latest Price
13.680
1 Day change
2.01%
52 Week Range
18.680
Analysis Updated At
2026/03/27
Should I buy Analysis is updated weekly. For real time "Should I Buy" analysis, please sign up to get free answers.
Sign Up

InMode Ltd (INMD) is not a strong buy at the moment for a beginner investor with a long-term focus. While the stock has a neutral technical setup and no significant positive catalysts, the recent financial performance shows a sharp decline in net income and EPS, which raises concerns about growth sustainability. The absence of strong trading signals and influential trading activity further supports a hold recommendation.

Technical Analysis

The MACD is positive and expanding, indicating a mild bullish momentum. RSI is neutral at 57.592, and moving averages are converging, suggesting no clear trend. Key support and resistance levels are close to the current price, indicating limited immediate upside potential.

Options Data

Bullish
Open Interest Put-Call Ratio
Bullish
Option Volume Put-Call Ratio

Technical Summary

StrongSellSellNeutralBuyStrongBuydotted line Image
Sell
6
Buy
7

Positive Catalysts

  • NULL identified. No recent news or significant trading activity from hedge funds, insiders, or politicians.

Neutral/Negative Catalysts

  • Financial performance in Q4 2025 shows a significant decline in net income (-67.35% YoY) and EPS (-62.83% YoY). Gross margin also dropped slightly (-1.34% YoY).

Financial Performance

In Q4 2025, revenue increased by 6.13% YoY to $103.85M. However, net income dropped sharply by 67.35% YoY to $27.03M, and EPS fell by 62.83% YoY to $0.42. Gross margin decreased slightly to 78.28%.

Growth

Profitability

Efficiency

Analyst Ratings and Price Target Trends

Baird analyst Jeff Johnson raised the price target to $17 from $16 but maintained a Neutral rating, reflecting a cautious outlook despite the slight price target increase.

Wall Street analysts forecast INMD stock price to rise
5 Analyst Rating
Wall Street analysts forecast INMD stock price to rise
1 Buy
4 Hold
0 Sell
Hold
Current: 13.680
sliders
Low
15
Averages
17.33
High
21
Current: 13.680
sliders
Low
15
Averages
17.33
High
21
Baird
Jeff Johnson
Neutral
maintain
$16 -> $17
AI Analysis
2026-02-11
Reason
Baird
Jeff Johnson
Price Target
$16 -> $17
AI Analysis
2026-02-11
maintain
Neutral
Reason
Baird analyst Jeff Johnson raised the firm's price target on InMode to $17 from $16 and keeps a Neutral rating on the shares. The firm updated its model following Q4 results.
Canaccord
Hold
downgrade
$16 -> $15
2025-12-17
Reason
Canaccord
Price Target
$16 -> $15
2025-12-17
downgrade
Hold
Reason
Canaccord lowered the firm's price target on InMode to $15 from $16 and keeps a Hold rating on the shares. The firm said they are bullish on the Med-Tech sector heading into 2026 as they expect investor interest given smid-cap valuations continue to remain depressed, while M&A has picked up and the IPO market has opened in some respects. They also highlight how AI is changing our space, enabling improved patient outcomes, increased procedure volumes, more efficiency at the corporate level, and improved surgical accuracy/reproducibility, which they believe could drive some of the greatest changes in healthcare at a time when the system is capacity constrained and in desperate need of solutions.
Unlock Full Analyst Thesis, Get the complete breakdown of rating reason for INMD
Unlock Now

People Also Watch